相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update
J. Maertens et al.
BONE MARROW TRANSPLANTATION (2011)
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections
Deniz Yilmaz et al.
MYCOSES (2011)
Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study
R. Herbrecht et al.
BONE MARROW TRANSPLANTATION (2010)
A Randomized, Double-Blind, Multicenter Study of Caspofungin Versus Liposomal Amphotericin B for Empiric Antifungal Therapy in Pediatric Patients With Persistent Fever and Neutropenia
Johan A. Maertens et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2010)
Pharmacokinetics and Safety of Caspofungin in Older Infants and Toddlers
Michael Neely et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality
F. L. Dignan et al.
BONE MARROW TRANSPLANTATION (2009)
Diagnosis and treatment of aspergillosis in children
Lyn Thomas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Safety, tolerance and outcome of treatment with liposomal amphotericin B in paediatric patients with cancer or undergoing haematopoietic stem cell transplantation
Hedwig Kolve et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
A Prospective, Multicenter Study of Caspofungin for the Treatment of Documented Candida or Aspergillus Infections in Pediatric Patients
Theoklis E. Zaoutis et al.
PEDIATRICS (2009)
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
Ray Y. Hachem et al.
CANCER (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Liposomal amphotericin B associated with severe hyperphosphatemia
Scott M. Sutherland et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Pediatric invasive aspergillosis: A multicenter retrospective analysis of 139 contemporary cases
Ana Burgos et al.
PEDIATRICS (2008)
Liposomal amphotericin B prophylaxis of invasive mold infections in children post allogeneic stem cell transplantation
Elizabeth Roman et al.
PEDIATRIC BLOOD & CANCER (2008)
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients
Lillian S. Chou et al.
PHARMACOTHERAPY (2007)
Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients
Simone Cesaro et al.
BMC INFECTIOUS DISEASES (2007)
Efficacy and safety of caspofungin therapy in children with invasive fungal infections
Etienne Merlin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey
AH Groll et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
High-dose weekly AmBisome antifungal prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation: A pharmacokinetic study
P Mehta et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Caspofungin treatment in severely ill, immunocompromised patients: a case-documentation study of 118 patients
A Glasmacher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Mycoses in pediatric patients
William J. Steinbach et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis
TE Zaoutis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents
TJ Walsh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant
E Castagnola et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
TJ Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis
S Cesaro et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2004)
Retrospective study of the safety of caspofungin in immunocompromised pediatric patients
JA Franklin et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2003)
Triad of acute infusion-related reactions associated with liposomal amphotericin B: Analysis of clinical and epidemiological characteristics
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2003)
Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients
PJ Cagnoni
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
